Navigation Links
B. Braun Launches 3L Sterile Water for Irrigation Container
Date:11/4/2013

BETHLEHEM, Pa., Nov. 4, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today the launch of a new Sterile Water for Irrigation 3L container. This new addition is part of B.Braun's expanding TITAN XL line of large-volume, flexible containers.

"This is the second launch of our growing line of safe, effective and eco-friendly fluid therapy solutions within B.Braun's TITAN XL line," said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun. "We recently announced the launch of  TITAN XL 3L 0.9% Sodium Chloride for Irrigation and have plans to further expand our TITAN XL portfolio over the next several months," added Williamson.   

B.Braun continues to lead the way in the healthcare industry by impacting the way hospitals evaluate and purchase their products – a true testament to B.Braun's ecological awareness and patient-centric philosophy. With the addition of the new TITAN XL containers, B.Braun will expand its line of solution containers that are not made with natural rubber latex, DEHP or PVC. Exposure to these toxic materials has been a growing concern for healthcare facilities around the world. Studies show that excessive exposure to DEHP can potentially lead to adverse health effects, especially to a patient's liver, kidneys and lungs, as well as their heart rate and blood pressure.[1] More than three decades ago, B.Braun recognized the environmental and patient risks posed by products containing DEHP and PVC. As a result, B.Braun was the first medical device manufacturer to remove these harmful substances from many products and today is the only supplier that offers a full line of solution containers that are not made with DEHP or PVC. B.Braun is keenly focused on continuing to find alternative methods to manufacture safer products such as the TITAN XL irrigation bags. 

About TITAN
The TITAN XL containers offer irrigation and coming soon parenteral nutrition solutions for compounding in large-volume, flexible bags. TITAN XL is highly transparent for quick volume monitoring and the innovative, convenient port system allows for easier access. The TITAN XL container is not made with natural rubber latex, DEHP or PVC and is compatible with most drugs. TITAN XL is stored at room temperature. B.Braun will be launching a series of TITAN XL containers for Irrigation and Clinical Nutrition beginning in 2013 and throughout 2014.

Customers interested in more information click here or call 888.422.7286 (888.4BBRAUN).

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

[1] http://www.wsna.org/Topics/Workplace-Environment-You/Environmental-Hazards/PVC-DEHP/


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at INS
2. B. Braun Purchases Land To Build New North American Headquarters
3. B. Braun Signs U.S. Distributor Agreement for Dialysis Water Purification Systems
4. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
5. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
6. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
7. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
8. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
9. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
10. B. Braun Committed To Improving Patient Safety
11. B. Braun Reveals Customer Satisfaction Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):